CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
NET (LOSS) ATTRIBUTABLE TO MANHATTAN SCIENTIFICS, INC.	$ (4,199,000)	$ 6,920,000
Net income (loss) attributable to noncontrolling interest
Adjustments to reconcile net income/(loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	365,000	428,000
Gain on FV of Investments	3,373,000	(203,000)
Gain on deconsolidation of subsidiary		(7,940,000)
Changes in:
Accounts receivable		30,000
Prepaid expenses	3,000	(3,000)
Accounts payable and accrued expenses	69,000	300,000
Deferred revenue	250,000	(1,000)
Net cash provided by/(used in) operating activities	(139,000)	(469,000)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Net cash provided by financing activities
NET INCREASE IN CASH AND CASH EQUIVALENTS	(139,000)	(469,000)
Cash and cash equivalents, beginning of year	269,000	1,068,000
CASH AND CASH EQUIVALENTS, END OF YEAR	130,000	599,000
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid
Income taxes paid